
Always respectful and encouraging to all.
Always patient, kind, and understanding.
Fosters collaboration and teamwork.
Creates a positive and welcoming vibe.
Peter Carne serves as an Adjunct Senior Lecturer in the Surgery Alfred Hospital department at Monash University and as a Senior Lecturer at Cabrini Monash University Department of Surgery. He holds the qualifications of MB BS and FRACS. He is a Member of the Colorectal Surgical Society of Australia and New Zealand (CSSANZ) and an International Fellow of the American Society of Colon and Rectal Surgeons (ASCRS). His specialist training was undertaken through the CSSANZ training program, including a Colorectal Fellowship at the Mayo Clinic in the United States. Additionally, he is accredited by the Conjoint Committee for Recognition of Training in Gastrointestinal Endoscopy.
As a colorectal surgeon, Peter Carne specializes in the management of diseases of the colon, rectum, and anus. His special interests include colorectal cancer, including recurrent rectal cancer; appendiceal tumours; pelvic tumours, such as presacral tumours; inflammatory bowel disease; diverticular disease; stomas; rectal prolapse; and perianal conditions. Areas of technical expertise encompass open, robotic, and laparoscopic colorectal surgery, colonoscopy, colonic stents, and transanal endoscopic microsurgery. He is the Director of the Colorectal Surgery unit at the Alfred Hospital and holds memberships in Cancer Council Victoria, the VCOG Gastrointestinal Cancer committee, and the Australasian Gastrointestinal Trials Group. Peter Carne's research outputs total 16, primarily articles from 2003 to 2023, focusing on colorectal surgery. Key publications include "Topical nifedipine for post-haemorrhoidectomy pain relief: randomized, prospective, double-blind trial protocol" (2023, BJS Open), "Surgical Techniques for Abdominoperineal Resection for Rectal Cancer: One Size Does Not Fit All" (2022, Frontiers in Surgery), "The National Aeronautics and Space Administration-task load index: NASA-TLX: evaluation of its use in surgery" (2022, ANZ Journal of Surgery), "Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres" (2018, International Journal of Surgery), and "Surgical outcome after standard abdominoperineal resection: A 15-year cohort study from a single cancer centre" (2018, Annals of Medicine and Surgery).